Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 100.
28. lappuse
... potassium levels in pa- tients being treated with digoxin . Potassium wastage may result from diu- retic or corticosteriod therapy , hemo- dialysis , and from suction of gastrointestinal secretions . It may accompany malnutrition ...
... potassium levels in pa- tients being treated with digoxin . Potassium wastage may result from diu- retic or corticosteriod therapy , hemo- dialysis , and from suction of gastrointestinal secretions . It may accompany malnutrition ...
29. lappuse
... potassium well tolerated . Continuous electrocardiographic monitor- ing should be performed to watch for any evidence of potassium toxicity , e.g. , peaking of T waves , and to observe the effect on the arrhythmia so that the infusion ...
... potassium well tolerated . Continuous electrocardiographic monitor- ing should be performed to watch for any evidence of potassium toxicity , e.g. , peaking of T waves , and to observe the effect on the arrhythmia so that the infusion ...
30. lappuse
... potassium . ) Potassium preparations may be given orally in divided doses totaling 1-1.5 milliequivalents / kilogram ( 1 gram K contains 13.4 milliequivalents ) . When correc- tion of the arrhythmia is urgent , approxi- mately 0.5 ...
... potassium . ) Potassium preparations may be given orally in divided doses totaling 1-1.5 milliequivalents / kilogram ( 1 gram K contains 13.4 milliequivalents ) . When correc- tion of the arrhythmia is urgent , approxi- mately 0.5 ...
52. lappuse
... potassium io- dide ) Ipecac Ipecac fluidextract Ipecac syrup Menthol / peppermint oil Pine tar preparations ( extract white pine compound , pine tar , syrup of pine tar , com- pound white pine syrup , white pine ) Potassium ...
... potassium io- dide ) Ipecac Ipecac fluidextract Ipecac syrup Menthol / peppermint oil Pine tar preparations ( extract white pine compound , pine tar , syrup of pine tar , com- pound white pine syrup , white pine ) Potassium ...
53. lappuse
... Potassium bicarbonate Potassium carbonate Protease Prolase Rhubarb fluid extract Senna Sodium chloride Sodium salicylate Stem bromelain Strawberry Strychnine Tannic acid Trillium Woodruff ( iii ) Charcoal , activated ( 9 ) [ Reserved ] ...
... Potassium bicarbonate Potassium carbonate Protease Prolase Rhubarb fluid extract Senna Sodium chloride Sodium salicylate Stem bromelain Strawberry Strychnine Tannic acid Trillium Woodruff ( iii ) Charcoal , activated ( 9 ) [ Reserved ] ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning